Table 1 Clinical characteristics of the patients
All casesHistological cirrhosis in biopsy groupPossible cirrhosisProbable cirrhosis
YesNop ValueYesNop ValueYesNop Value
Number of patients (%)146632 (24)102 (76)465 (32)1001 (68)187 (13)1279 (87)
Male gender (%)939 (64)29 (91)74 (73)0.03351 (76)588 (59)<0.001144 (77)795 (62)<0.001
Age, mean (SD), year46 (12)46 (8)43 (12)0.1349 (12)44 (12)<0.00151 (12)45 (12)<0.001
Body weight, mean (SD), kg65 (12)70 (11)66 (11)0.1167 (12)64 (12)<0.00168 (12)64 (12)<0.001
Body height, mean (SD), cm166 (12)166 (10)167 (8)0.76166 (15)167 (10)0.58166 (21)167 (8)0.79
BMI, mean (SD), kg/m223 (3)26 (4)24 (3)0.0324 (4)23 (3)<0.00124 (4)23 (3)<0.001
Overweight (BMI⩾23 kg/m2, %)747 (51)23 (72)61 (60)0.22277 (60)470 (47)<0.001116 (62)631 (49)0.001
Obesity (BMI⩾25 kg/m2, %)393 (27)15 (47)32 (32)0.11170 (37)223 (22)<0.00173 (39)320 (25)<0.001
Moderate obesity (BMI⩾28 kg/m2,%)104 (7)8 (25)10 (10)0.0354 (11)50 (5)<0.00119 (10)85 (7)0.06
Severe obesity (BMI⩾30 kg/m2, %)42 (3)6 (19)3 (3)0.00227 (6)15 (2)<0.00111 (6)31 (2)0.01
Waist circumference, mean (SD), cm84 (10)89 (15)82 (9)0.0186 (10)83 (10)<0.00187 (11)83 (10)<0.001
Hip circumference, mean (SD), cm96 (26)98 (8)94 (7)0.0196 (8)96 (31)0.0597 (7)96 (28)0.16
Systolic blood pressure, mean (SD), mm Hg128 (19)131 (15)122 (15)0.002133 (20)125 (18)<0.001136 (21)127 (18)<0.001
Diastolic blood pressure, mean (SD), mm Hg76 (12)74 (11)69 (10)0.0378 (13)75 (11)<0.00179 (13)76 (12)<0.001
Metabolic syndrome (%)188 (13)12 (38)11 (11)<0.00195 (20)93 (9)<0.00145 (24)143 (11)<0.001
    Central obesity (%)605 (41)15 (47)32 (31)0.10213 (46)392 (39)0.0192 (49)513 (40)0.01
    Raised triglycerides (%)196 (13)6 (19)16 (16)0.6878 (17)118 (12)0.00632 (17)164 (13)0.07
    Reduced HDL-cholesterol (%)256 (18)4 (13)10 (10)0.66100 (22)156 (16)0.00446 (25)210 (16)0.005
    Hypertension (%)654 (45)18 (56)32 (31)0.01262 (56)392 (39)<0.001115 (62)539 (42)<0.001
    Diabetes mellitus (%)205 (14)15 (47)26 (26)0.02115 (25)90 (9)<0.00155 (29)150 (12)<0.001
Biochemical
    Albumin, mean (SD), g/l44 (4)42 (4)43 (5)0.0242 (5)45 (3)<0.00141 (6)44 (3)<0.001
    Bilirubin, mean (SD), μmol/l15 (12)17 (24)15 (9)0.3217 (18)14 (7)<0.00120 (17)14 (10)<0.001
    Alkaline phosphatase, mean (SD), IU/l75 (30)81 (26)79 (45)0.3185 (36)70 (23)<0.00195 (37)72 (26)<0.001
    Alanine transaminase, mean (SD), IU/l71 (136)95 (100)97 (79)0.69112 (216)53 (74)<0.001147 (304)61 (88)<0.001
    Alpha-fetoprotein, mean (SD), ng/l7 (32)10 (17)4 (4)0.00115 (53)3 (10)<0.00130 (82)4 (10)<0.001
Hepatitis B e antigen0.810.0020.009
    Positive (%)375 (25)59 (45)46 (45)136 (29)231 (23)60 (32)307 (24)
    Negative (%)791 (75)75 (55)56 (55)329 (71)770 (77)127 (68)972 (76)
log10 [HBV DNA], mean (SD), log10 copies/ml5.0 (1.9)5.7 (1.5)6.3 (2.0)0.185.5 (1.8)4.7 (1.9)<0.0015.8 (1.6)4.9 (1.9)<0.001
Liver stiffness measurement, mean (SD), kPa8.3 (6.3)14.5 (7.7)8.8 (5.2)<0.00114.7 (7.9)5.5 (1.4)<0.00121.3 (9.0)6.6 (2.4)<0.001
Interquartile range/LSM, mean (SD), %19 (16)17 (9)20 (14)0.0120 (14)18 (17)<0.00122 (16)18 (16)<0.001
Success rate of acquisition, mean (SD), %89 (13)90 (14)89 (15)0.8390 (13)89 (13)0.0191 (13)89 (13)0.03
  • BMI, body mass index; HBV, hepatitis B virus; LSM, liver stiffness measurement; SD, standard deviation.